Table 1 |
||
|
Interstitial lung diseases associated with connective tissue diseases |
||
|
Rheumatic disease |
Frequency of ILD (%) |
Comment |
|
|
||
|
Systemic sclerosis |
45 (clinically significant) |
More common in diffuse disease; topoisomerase-1 antibodies |
|
Rheumatoid arthritis |
20 to 30 |
Increased risk with cigarette smoking |
|
Polymyositis/dermatomyositis |
20 to 50a |
More common with anti-synthetase antibodies |
|
Sjögren's syndrome |
Up to 25 |
- |
|
Systemic lupus erythematosus |
2 to 8 |
Usually in patients with multisystem disease |
|
Mixed connective tissue disease |
20 to 60 |
- |
|
|
||
|
ILD, interstitial lung disease. aFrequency may be higher based on recent studies. |
||
|
Castelino and Varga Arthritis Research & Therapy 2010 12:213 doi:10.1186/ar3097 |
||